These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 2594732
1. Evaluation of hypothalamic dopaminergic function in patients with pituitary prolactinoma. Xia P, Shi YF. Proc Chin Acad Med Sci Peking Union Med Coll; 1989; 4(3):121-5. PubMed ID: 2594732 [Abstract] [Full Text] [Related]
2. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. Fine SA, Frohman LA. J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585 [Abstract] [Full Text] [Related]
3. [Molecular heterogeneity of prolactin and gonadotropins in some forms of sterility]. Morán C, Fonseca ME, Ochoa R, Masón M, Gama R, Zárate A. Ginecol Obstet Mex; 1990 Apr; 58 Suppl 1():9-13. PubMed ID: 2125965 [Abstract] [Full Text] [Related]
4. Postoperative evaluation of dopaminergic tone in prolactinoma patients. II. Plasma thyrotropin response to metoclopramide. De Marinis L, Mancini A, Maira G, Anile C, Menini E, Barbarino A. J Clin Endocrinol Metab; 1984 Mar; 58(3):405-9. PubMed ID: 6693543 [Abstract] [Full Text] [Related]
5. Catecholamines and pituitary function. 2. Prolactin response to different dopamine doses in normal cycling women and patients with prolactin-secreting pituitary tumors, both before and after endogenous catecholamine synthesis inhibition. Nicoletti I, Filipponi P, Fedeli L, Gregorini G, Ambrosi F, Sfrappini M, Santeusanio F, Brunetti P. Horm Metab Res; 1984 Dec; 16(12):658-62. PubMed ID: 6441763 [Abstract] [Full Text] [Related]
6. Monoamine regulation of prolactin and TSH secretion in hypothyroidism. Gerasimov G, Chernova T, Goncharov N. Acta Med Austriaca; 1992 Dec; 19 Suppl 1():86-8. PubMed ID: 1519463 [Abstract] [Full Text] [Related]
7. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment. Sartorio A, Pizzocaro A, Liberati D, De Nicolao G, Veldhuis JD, Faglia G. Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874 [Abstract] [Full Text] [Related]
8. Treatment of macroprolactinoma with the new potent non-ergot D2-dopamine agonist quinagolide and effects on prolactin levels, pituitary function, an the renin-aldosterone system. Results of a clinical long-term study. Nickelsen T, Jungmann E, Althoff P, Schumm-Draeger PM, Usadel KH. Arzneimittelforschung; 1993 Apr; 43(4):421-5. PubMed ID: 8098604 [Abstract] [Full Text] [Related]
9. Prl, TSH, GH and LH responses to metoclopramide and breast-feeding in normal and hyperprolactinaemic women. Andersen AN, Tabor A. Acta Endocrinol (Copenh); 1982 Jun; 100(2):177-83. PubMed ID: 7202316 [Abstract] [Full Text] [Related]
10. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma. Gordon D, Richards A, Bulloch R, Cohen HN, Semple CG, Beastall GH, Thomson JA, Teasdale G. Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723 [Abstract] [Full Text] [Related]
11. [The value of functional tests in diagnosis of prolactinoma]. Klockenbusch W, Distler W, von Ditfurth M, Graf M, Jahn K. Geburtshilfe Frauenheilkd; 1990 May; 50(5):383-7. PubMed ID: 2115483 [Abstract] [Full Text] [Related]
12. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment. Zacharieva S, Stoeva I, Andreeva M, Kalinov K, Matrozov P, Andonova K. Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834 [Abstract] [Full Text] [Related]
13. Reduced dopaminergic inhibition of thyrotropin release in hyperprolactinemic ovulatory women. Larrea F, Escorza A, Valencia X, Méndez I, Schiavon R, Forsbach G. Rev Invest Clin; 1991 Nov; 43(4):293-8. PubMed ID: 1798861 [Abstract] [Full Text] [Related]
14. Hypothalamic-pituitary evaluation in patients with galactorrhea-amenorrhea and hyperprolactinemia. Badawy SZ, Nusbaum ML, Omar M. Obstet Gynecol; 1980 Jan; 55(1):1-7. PubMed ID: 6243406 [Abstract] [Full Text] [Related]
15. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery. Barbarino A, De Marinis L, Anile C, Menini E, Merlini G, Maira G. Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636 [Abstract] [Full Text] [Related]
16. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma. De Leo V, Petraglia F, Sardelli S, Danero S, Genazzani AR, D'Antona N. Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236 [Abstract] [Full Text] [Related]
17. Impaired growth hormone secretion in patients operated for pituitary adenomas. Hoeck HC, Bang F, Laurberg P. Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904 [Abstract] [Full Text] [Related]
18. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma. Hanew K, Utsumi A, Sugawara A, Shimizu Y, Yoshinaga K. Acta Endocrinol (Copenh); 1991 May; 124(5):545-52. PubMed ID: 1903012 [Abstract] [Full Text] [Related]
19. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients. De Marinis L, Mancini A, Minnielli S, Masala R, Anile C, Maira G, Barbarino A. Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835 [Abstract] [Full Text] [Related]
20. Evidence of abnormal dopaminergic control of prolactin in patients with hypothalamic and pituitary tumors. Cabranes JA, Almoguera I, del Olmo J, Prensa A, Pablos I, Charro AL. J Med; 1986 Oct; 17(1):25-39. PubMed ID: 3035040 [Abstract] [Full Text] [Related] Page: [Next] [New Search]